Award
NIH Reporter #11606576
Heparan sulfate-mediated mechanisms of alpha-synuclein pathology in dementia with Lewy bodies disease
Recipient
Not specified
Award Amount
$499,648.00
Ceiling
$499,648.00
Awarded
August 31, 2026
Identifier
11606576
NIH-funded research project studying heparan sulfate's role in alpha-synuclein pathology in dementia with Lewy bodies, including drug testing.
Description
This is a research project funded by the NIH focusing on the role of heparan sulfate in alpha-synuclein pathology related to dementia with Lewy bodies. The project involves in vitro and in vivo studies, as well as testing of HS-targeted drugs.